These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18174620)

  • 21. Coronary stent fracture complicated multiple aneurysms confirmed by 3-dimensional reconstruction of intravascular-optical coherence tomography in a patient treated with open-cell designed drug-eluting stent.
    Kim S; Kim CS; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ; Yoo H; Kim JW
    Circulation; 2014 Jan; 129(3):e24-7. PubMed ID: 24446412
    [No Abstract]   [Full Text] [Related]  

  • 22. Chest Pain in a 39-Year-Old Man: What Could Be the Underlying Cause?
    Plastiras SC; Zampeli E; Moutsopoulos HM
    Am J Med; 2016 Dec; 129(12):e329-e330. PubMed ID: 27403601
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronary artery aneurysms associated with a Paclitaxel coated stent.
    Wang D; Gunalingam B
    Heart Lung Circ; 2008 Feb; 17(1):66-9. PubMed ID: 17419098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
    Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S
    J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stent fracture: an unusual cause of late restenosis after sirolimus-eluting stent placement.
    Mehrle A; Skelton T; Almonacid A
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):988-91. PubMed ID: 17191207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Techniques, strategies, and dogmas in bifurcation stenting and side branch protection: some food for thought.
    Tan WA
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):757-8. PubMed ID: 25322714
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of a double-bifurcation lesion with sirolimus-eluting stents using the "sleeve technique".
    Jim MH; Ho HH; Chow WH
    J Invasive Cardiol; 2007 Jan; 19(1):E10-4. PubMed ID: 17297189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provisional side branch stenting: presentation of an automated method allowing online 3D OCT guidance.
    Ughi GJ; Dubois C; Desmet W; D'hooge J; Adriaenssens T
    Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):715. PubMed ID: 23389734
    [No Abstract]   [Full Text] [Related]  

  • 31. Antithrombotics and stent type for primary PCI.
    Mukherjee D
    Lancet; 2011 Jun; 377(9784):2154-6. PubMed ID: 21665264
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.
    Fanggiday JC; Stella PR; Guyomi SH; Doevendans PA
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):629-35. PubMed ID: 18360855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of Takotsubo cardiomyopathy with COVID 19.
    Nguyen D; Nguyen T; De Bels D; Castro Rodriguez J
    Eur Heart J Cardiovasc Imaging; 2020 Sep; 21(9):1052. PubMed ID: 32395765
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug for a while, polymer for life: Is it a good solution?
    Kastrati A
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):340-1. PubMed ID: 18288754
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions.
    Fonseca A; Costa Jde R; Abizaid A; Feres F; Abizaid AS; Costa R; Staico R; Mattos LA; Sousa AG; Grube E; Sousa JE
    J Invasive Cardiol; 2008 Jan; 20(1):21-7. PubMed ID: 18174614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Full-plastic jacket' with bioresorbable vascular scaffolds: 5-year optical coherence tomography follow-up.
    Nai Fovino L; Barioli A; Tarantini G
    Eur Heart J Cardiovasc Imaging; 2019 Mar; 20(3):370. PubMed ID: 30561565
    [No Abstract]   [Full Text] [Related]  

  • 37. Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.
    Park SJ
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):13-4. PubMed ID: 21181967
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute coronary syndrome secondary to a complex lesion within a stent implanted over 6 years previously.
    Baker DM; Osborn LA
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):366-8. PubMed ID: 12822161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions.
    Ruef J; Störger H; Schwarz F; Haase J
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):333-9. PubMed ID: 18288747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.